SAWAF AZIZ (SVP & CHIEF FINANCIAL OFFICER) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/24/2026ACC: 0001961289-26-000008
Officer· SVP & CHIEF FINANCIAL OFFICER
Since Feb 2026
-8.11K
Net shares
Net seller
$137.5K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.11K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−8.11K
Price / share
$16.95
Trade value
$137.50K
% of position
2.4%
8/20/2026
344.95K→336.84K
Total
Net shares
−8.11K
Net value
-$137.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2026 | F · Tax Withholding | −8.11K | $16.95 | $137.50K | 2.4% | 344.95K | 336.84K |
| Total | −8.11K | -$137.50K | ||||||
Derivative Transactions0
No derivative transactions reported